Product Categories
Country: | China |
---|---|
Tel: | 027-88237510 |
Mobile: | 15827267957 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
Vandetanib | C22H24BrFN4O2 | 443913-73-3 | Details |
Olaparib | C24H23FN4O3 | 763113-22-0 | Details |
Foretinib (GSK1363089) | C34H34F2N4O6 | 849217-64-7 | Details |
LY2835219 | C28H36F2N8O3S | 1231930-82-7 | Details |
PF-06463922 | C21H19FN6O2 | 1454846-35-5 | Details |
Lapatinib Ditosylate | C36H34ClFN4O7S2 | 388082-77-7 | Details |
Crizotinib | C21H22Cl2FN5O | 877399-52-5 | Details |
Lenvatinib (E7080) | C21H19ClN4O4 | 417716-92-8 | Details |
Ibrutinib | C25H24N6O2 | 936563-96-1 | Details |
ponatinib; AP-24534 | C29H27F3N6O | 943319-70-8 | Details |
Cediranib Maleate(AZD-2171) | C25H27FN4O3·C4H4O4 | 857036-77-2 | Details |
Bambuterol Hydrochloride | C18H30ClN3O5 | 81732-46-9 | Details |
Triptolide | C20H24O6 | 38748-32-2 | Details |
Sunitinib Malate | C26H33FN4O7 | 341031-54-7 | Details |
AZD8931 (Sapitinib) | C23H25ClFN5O3 | 848942-61-0 | Details |
Cabozantinib L-Malate | C32H30FN3O10 | 1140909-48-3 | Details |
Dacomitinib,PF299804 | C24H25ClFN5O2 | 1110813-31-4 | Details |
Erlotinib hydrochloride | C22H24ClN3O4 | 183319-69-9 | Details |
Neratinib | C30H29ClN6O3 | 698387-09-6 | Details |
Lapatinib Ditosylate | C41H40ClFN4O11S3 | 388082-78-8 | Details |
Regorafenib | C21H15ClF4N4O3 | 755037-03-7 | Details |
Trametinib (GSK1120212) | C26H23FIN5O4 | 871700-17-3 | Details |
Cediranib (AZD2171) | C25H27FN4O3 | 288383-20-0 | Details |
MK-677 | C28H40N4O8S2 | 159752-10-0 | Details |
Pazopanib hydrochloride | C21H24ClN7O2S | 635702-64-6 | Details |
lenvatinib Mesylate | C22H23ClN4O7S | 857890-39-2 | Details |
Ap26113; brigatinib | C29H39ClN7O2P | 1197953-54-0 | Details |
Dasatinib | C22H26ClN7O2S | 302962-49-8 | Details |
Linifanib (ABT-869) | C21H18FN5O | 796967-16-3 | Details |
WZ4002 | C25H27ClN6O3 | 1213269-23-8 | Details |
Regorafenib monohydrate | C21H17ClF4N4O4 | 1019206-88-2 | Details |
ponatinib; AP-24534 | C29H28ClF3N6O | 1114544-31-8 | Details |
Niraparib | C26H28N4O4S | 1038915-73-9 | Details |
AZD3759 | C22H23ClFN5O3 | 1626387-80-1 | Details |
MK-4827; Niraparib TsOH salt hydrate | C26H28N4O4S | 1613220-15-7 | Details |
Superoxide Dismutase, SOD | NULL | 9054-89-1 | Details |
Imatinib Mesilate | C30H35N7O4S | 220127-57-1 | Details |
BIBF 1120 | C31H33N5O4 | 656247-17-5 | Details |
Cabozantinib;XL184 | C28H24FN3O5 | 849217-68-1 | Details |
LCZ696 | C48H58N6O8 | 936623-90-4 | Details |
Axitinib | C22H18N4OS | 319460-85-0 | Details |
Gefitinib | C22H24ClFN4O3 | 184475-35-2 | Details |
Selumetinib;AZD6244 | C17H15BrClFN4O3 | 606143-52-6 | Details |
BKM120 (NVP-BKM120, Buparlisib) | C18H21F3N6O2 | 944396-07-0 | Details |
Niraparib | C19H20N4O | 1038915-60-4 | Details |
MK-1775 | C27H32N8O2 | 955365-80-7 | Details |
Baricitinib | C16H17N7O2S | 1187594-09-7 | Details |
Ceritinib (LDK378) | C28H36ClN5O3S | 1032900-25-6 | Details |
EAI-045 | C19H14FN3O3S | 1942114-09-1 | Details |
Bortezomib | C19H25BN4O4 | 179324-69-7 | Details |
Tasocitinib citrate | C16H20N6O.C6H8O7 | 540737-29-9 | Details |
INC280 | C23H17FN6O | 1029712-80-8 | Details |
Entrectinib;RXDX-101 | C31H34F2N6O2 | 1108743-60-7 | Details |
everolimus | C53H83NO14 | 159351-69-6 | Details |
Entecavir hydrate | C12H17N5O4 | 209216-23-9 | Details |
Product Total: Product Page: | ||||
1 |